Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adriamycin + Taxotere vs. Adriamycin + Cyclophosphamide in Advanced Breast Cancer
NCT00003679Phase 3Unknown
- Sponsor
- Scottish Cancer Therapy Network
- Start
- Nov 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by Scottish Cancer Therapy Network. Status: unknown.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003679.